Immuron’s IMM-124E Significantly Eases Symptoms of Chronic Colitis in Mouse Model, Company Reports

Immuron’s IMM-124E Significantly Eases Symptoms of Chronic Colitis in Mouse Model, Company Reports
Immuron’s investigational therapy IMM-124E significantly reduced intestinal inflammation in mice models of chronic colitis, the company reports. These results add to previous preclinical evidence showing the therapy to also of benefit in acute models of colitis, strengthening IMM-124E’s potential as an inflammatory bowel disease (IBD) treatment. A presentation of this data is set for the United European

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *